Hong Yan, Liu Guodong, Gu Zhengbiao
a The State Key Laboratory of Food Science and Technology .
b School of Food Science and Technology , and.
Drug Deliv. 2016;23(1):12-20. doi: 10.3109/10717544.2014.913324. Epub 2014 May 15.
In recent years, polysaccharides, including starch and its derivatives, have been widely used in the pharmaceutical industry, including as diluents, fillers, binders, disintegrants and glidants. The use of native starch as excipient in extended-release tablets is limited due to its low compactibility and enzymatic degradability, leading to the formation of weakly structured tablets. To overcome these limitations and expand the application of starch as an excipient, researchers have modified starch by physical and chemical methods, as well as by enzymatic hydrolysis. Some starch derivatives, including retrograded starch, pregelatinized starch, carboxymethyl starch, starch acetate, cross-linked starch and grafted starch have recently been introduced as excipients in oral tablets to control drug release. In this review, applications of starch and its derivatives as extended release excipients are reviewed and future frontiers are described.
近年来,包括淀粉及其衍生物在内的多糖已在制药工业中广泛应用,用作稀释剂、填充剂、黏合剂、崩解剂和助流剂等。由于天然淀粉的低压缩性和酶促降解性,其在缓释片中作为辅料的应用受到限制,这会导致片剂结构松散。为克服这些限制并扩大淀粉作为辅料的应用范围,研究人员已通过物理和化学方法以及酶促水解对淀粉进行改性。一些淀粉衍生物,包括回生淀粉、预胶化淀粉、羧甲基淀粉、醋酸淀粉、交联淀粉和接枝淀粉,最近已被引入口服片剂中作为辅料以控制药物释放。在本综述中,对淀粉及其衍生物作为缓释辅料的应用进行了综述,并描述了未来的前沿领域。